Are you #researching 🔬 #gut or #liver disease?
Want to connect with researchers across London?
Looking for #PPIE support?
Need feedback on your next grant application?
Sign up for free at https://t.co/o0G4Mhf3IU to #collaborate on projects across #hepatology#gastroenterology
It was great to interview Prof Alex Ford @alex_ford12399 with @dr_aditi_kumar for the #FGPodcast - any aspiring academic (& in fact established academic) should listen to it - so many lessons and this is just Part 1. Part 2 and 3 will be out soon! @FrontGastro_BMJ@BritSocGastro
Now @LancetGastroHep Appendicectomy showed superior efficacy similar safety over JAKi in UC patients after a biologic failure!
1yr remission 33% vs 12%. Response 73% vs 53%
Joins previous high quality trials w/similar results
Call it appendicectuzumab and lets go
https://t.co/LquMRbpSyz
One of the most common questions in any IBD clinic is: What should I eat?
Beatriz Gros, consultant gastroenterologist and researcher, shares the landmark dietary results from the PREdiCCt study, now published in Gut.
We studied the habitual diets of over 1,000 patients in remission for up to four years to find clear answers. While we found no consistent signals from fiber or ultra-processed foods, we identified a significant association between meat intake and flare risk in ulcerative colitis.
This research provides a much-needed evidence base to help clinicians and patients make informed choices about diet and long-term disease management.
Watch the video to learn more about how diet influences IBD flare risk.
Grateful to have worked with this amazing team on this project! @ChhibbaTarun @gilkaplan
To curb the rapid rise of IBD, we must understand both risk & protective factors
Our latest research explores key environmental influences to guide prevention strategies
https://t.co/4xbGNBr3Ng
On the Need for Equipoise and Placebos: - Gastroenterology https://t.co/MWvgAGMpUu @JamesLewisGIEpi 👇🏽commentary exploring the comparison of sc Infliximab and sc Vedolizumab against placebo and not the standard iv formulations: implications of poor trial designs😔who benefits?
Best summaries of IBD trials here are done by @laura_tee_mdgi
Now, a new milestone 🌟has been reached with "too long didnt read" @TLDR_IBD where IBD papers are explained & analyzed in < 5 min
1st episode EXIT trial from @geteccu 🇪🇸@maria_chs@jp_gisbert et al @Gut_BMJ
This is something l've always hoped for, and there's so much to learn from it!
I’m really excited to join the amazing editorial board of @FrontGastro_BMJ as an Associate Editor for #IBD!
Frontline Gastroenterology is the journal for directly improving patients’ lives now & it’s great to be a part of it!
What a team @PhilSmithIsBack !
Researchers from the Crick, @SickKidsNews and @JohnsHopkins have discovered a recycling mechanism that’s essential for keeping mitochondria healthy.
It could become a future target to diagnose and treat conditions related to mitochondrial dysfunction.
https://t.co/JpZon8CUKd
There's been amazing coverage of our new paper @Nature https://t.co/qkrUksBYVW but I wanted to put together a walk-through (and make this accessible as possible). It's a bit long so get a cup of tea! The full version is open access so pls do have a read if you are interested...
Very excited to share our new pre-print ‘SIGNAL-seq: Multimodal Single-cell Inter- and Intra-cellular Signalling Analysis’ led by @j_opzoomer. (1/11)
https://t.co/jUFS503Trd
We will hold another symposium late 2024 so don’t forget to join almost 100 researchers on https://t.co/o0G4MhevTm and watch this space NEW features on ethics, PPIE and bioresources
Check out our latest flyer for #LGLN2024 - scan the QR code and join us on 26th Feb.
Don’t forget to sign up with https://t.co/mzkHpSn0Qf for free to get your promo code.
See you there!
Check out our latest flyer for #LGLN2024 - scan the QR code and join us on 26th Feb.
Don’t forget to sign up with https://t.co/mzkHpSn0Qf for free to get your promo code.
See you there!